Date: Thursday, November 2, 2017
Time: 1:00pm EST/ 10:00AM PST
How does your brand stack up against the competition? You can now find out with the recent launch of the first and only global peer-to-peer drug review system provided exclusively from verified licensed physicians.
With hundreds of thousands of ratings and thousands more added every day, Drug Ratings is quickly becoming the world’s largest dataset of physician perceptions on drugs. Drugs are rated according to their safety, efficacy, tolerability, and accessibility, and reviews often include commentary based on doctors’ real-world experiences.
Join this webcast and hear from SERMO CEO Peter Kirk on:
- How healthcare companies can gain completely new insights on true physician perceptions of drugs at the point of sale
- Why doctors behave as they do toward specific drugs and competitive treatments, and how this information can be useful to brands
- Actionable insights into how doctors view drugs to support perceived strengths and address perceived weaknesses.
Peter Kirk, CEO, Sermo